Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Total Assets (Quarterly): 6.754M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.754M |
June 30, 2024 | 9.47M |
March 31, 2024 | 6.349M |
December 31, 2023 | 8.881M |
September 30, 2023 | 11.16M |
June 30, 2023 | 14.76M |
March 31, 2023 | 20.31M |
December 31, 2022 | 25.08M |
September 30, 2022 | 27.91M |
June 30, 2022 | 30.55M |
March 31, 2022 | 33.30M |
December 31, 2021 | 35.10M |
September 30, 2021 | 35.88M |
June 30, 2021 | 38.29M |
March 31, 2021 | 39.92M |
December 31, 2020 | 21.58M |
September 30, 2020 | 20.64M |
June 30, 2020 | 25.62M |
March 31, 2020 | 28.44M |
December 31, 2019 | 31.31M |
September 30, 2019 | 37.77M |
June 30, 2019 | 43.45M |
March 31, 2019 | 40.62M |
December 31, 2018 | 39.68M |
September 30, 2018 | 42.62M |
Date | Value |
---|---|
June 30, 2018 | 45.09M |
March 31, 2018 | 49.83M |
December 31, 2017 | 53.55M |
September 30, 2017 | 56.91M |
June 30, 2017 | 61.71M |
March 31, 2017 | 69.18M |
December 31, 2016 | 76.13M |
September 30, 2016 | 57.54M |
June 30, 2016 | 58.85M |
March 31, 2016 | 67.58M |
December 31, 2015 | 74.54M |
September 30, 2015 | 81.68M |
June 30, 2015 | 90.56M |
March 31, 2015 | 53.49M |
December 31, 2014 | 52.07M |
September 30, 2014 | 56.54M |
June 30, 2014 | 46.91M |
March 31, 2014 | 50.19M |
December 31, 2013 | 51.62M |
September 30, 2013 | 54.90M |
June 30, 2013 | 14.51M |
December 31, 2012 | 16.75M |
September 30, 2012 | 9.043M |
June 30, 2012 | 9.709M |
March 31, 2012 | 11.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.349M
Minimum
Mar 2024
39.92M
Maximum
Mar 2021
23.56M
Average
25.35M
Median
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 24.07M |
AIM ImmunoTech Inc | 13.59M |
IGC Pharma Inc | 10.37M |
NovaBay Pharmaceuticals Inc | 3.877M |
Protalix BioTherapeutics Inc | 61.56M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.074M |
Shareholders Equity (Quarterly) | 3.68M |
Current Ratio | 1.981 |